PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388802
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388802
Omics is a term used to refer to various ranges of investigations including transcriptomics, genomics, metabolomics, and proteomics. The proteomics approaches and traditional transcriptomics have offered insight into disease progression by detecting discrete cellular subpopulations or micro environmental signature characteristics of pathological or normal tissues. The spatial pattern of the genome has been found for the treatment of various disorders because that spatial information is being employed as a diagnostic biomarker for determining the medical state. Additionally, special omics combine spatial information with molecular analysis of the cell's localization inside the tissue. Thus, this technology provides a powerful tool to comprehend crucial mechanisms such as cell regulation or tissue organization.
The rising prevalence of cancer in developed and developing economies, along with the robust growth of the geriatric population with chronic disorders such as cancer, extensively needs targeted analyses and studies of the intricate tumor micro-environment to comprehend tumor immunogenicity. This enhances the well-defined molecular profiles that are connected with immune cell exhaustion coupled with activation. Additionally, the rate of cancer cases has significantly increased, while death rates have exhibited a notable drop owing to enhanced treatments and earlier diagnosis. In line with this, this technology has become an integral and novel tool for the diagnosis of cancer. Thus, the demand for the global spatial OMICS market is anticipated to rise as a result of these novel diagnostic tool options. However, a lack of skilled professionals and limited research expertise available in this field is expected to restrain the market growth. Furthermore, technology advancements such as spatial transcriptomics, spatial proteomics, and spatial genomics, have enhanced the ability to analyze molecular information in cells and tissues at a spatial level. These advanced technologies offer researchers a comprehensive understanding of detailed biological systems.
The spatial omics market is driven by various factors, such as the increasing prevalence of a wide range of genetic illnesses, increased funding for spatial OMICS research, and global advances in sequencing technologies.
The global spatial omics market is segmented on the basis of technology, product, workflow, end use, and region.
The market is divided into three categories based on technology: spatial proteomics, spatial transcriptomics, and spatial genomics. The spatial transcriptomics segment is projected to possess the largest market share. In sequencing technologies, frequent innovations may augment the transcriptomic study of single cells. Additionally, the technology makes it easy to use the method to ascertain the subcellular localization of mRNA molecules. These technical methods frequently aid in the significant conjunction of the function-oriented area of biochemistry and molecular genetics with structure-focused areas, such as histology and embryology, thus enabling spatially determined molecular analysis of biological procedures.
The market is divided into three categories based on products: software, instruments, and consumables. The consumables segment is likely to maintain its dominance over the forecast period due to the introduction of innovative products in the market along with the growing use rate of the segment. Moreover, the software segment is accounted to witness the highest growth rate. The rising use of several tools for the analyses of the single-cell spatial OMICS data, statistical studies of the spatial pattern, consolidative analyses, and visualization of spatial expression data are the multiple factors that lead to the market demand for the segment.
By geographical analysis, the spatial omics market can be segmented into North America, Asia Pacific, Europe, and the Rest of the world. North America is likely to dominate the largest share due to the rising cases of cancer, well-developed healthcare facilities, the availability of novel diagnostic techniques, and the growing demand for personalized medicine. The increasing mortality and morbidity rates owing to cancer and other metabolic, inflammatory, and autoimmune disorders have led to an increasing requirement for developing novel therapies, thereby boosting the market in this region. Asia Pacific is projected to expand at the fastest period. Businesses are entering into agreements for enlarging their biological research activities, as a result, will drive the adoption of omics tools in the region.
The spatial omics market is anticipated to grow owing to its increased usage in drug research and development as well as its potential as a tool for cancer diagnosis. The growth observed by the emerging and existing companies in the market is leading to the important introduction of novel ideas that are expanding the adoption of spatial omics globally. Market players are emphasizing intensifying their spatial transcriptomics and genomic footprints by implementing growth strategies such as mergers and acquisitions, collaboration, and new partnerships to enhance their presence in the market. For instance, in May 2023, Mass., the life science business devoted to improving human well-being by imagining single-cell spatial genomics data, announced the launch of its MERSCOPE Platform Grant Program, open to researchers in North America and Europe.
For instance, in March 2021, Veranome Biosystems LLC unveiled the world's first complete sample-to-insight high-plex spatial omics solution for single-cell level characterization.
The scope of this report covers the market by its major segments, which include as follows: